Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

The investigators select 40 postmenopausal women suffering from RA with 2.5Phase:

N/AAccepts Healthy Volunteers? No

Details

• Lead Sponsor: Sara Saeidi Shahri
• Treatments: Raloxifene Hydrochloride

Criteria

Inclusion Criteria:

• Patients are postmenopausal women.

• Patients should fit at least 4 criteria of ACR-1987 criteria for rheumatoid arthritis.

• Patients should be in range of 2.5Exclusion Criteria:

• Patients with history of thrombotic events

• Patients suffering from another rheumatic diseases simultaneously

• Patients with sever symptoms of menopause

• Patients with known psychological diseases